Injectable Egg-Free Influenza Vaccine 2027

PresolicitationActive

Key Takeaways

  • Full and open competition - all businesses eligible to bid
  • Work to be performed in PHILADELPHIA, PA
  • Industry: Biological Product (except Diagnostic) Manufacturing
  • Advance notice of upcoming solicitation

Contract Details

Notice ID
SPE2DP26R0004
Opportunity Type
Presolicitation
Sub-Agency
DEFENSE LOGISTICS AGENCY
Office
DLA TROOP SUPPORT
Posted Date
Thursday, September 24, 2026
Response Deadline
Thursday, October 8, 2026
PSC Code
6505
Set-Aside
Full & Open Competition
Place of Performance
PHILADELPHIA, PA, 19111
Status
Active

Description

The Defense Logistics Agency Troop Support is soliciting for the supply of Injectable Egg-Free Influenza Vaccine for the 2027-2028 flu season. Approximately 300,000 doses are included in this requirement. (Quantities may increase or decrease pending receipt of final Service requirements.) The vaccines shall be in prefilled syringes presentation. The vaccine shall be FDA-approved for immunizing individuals 18 years and older. The formula for the 2027-2028 season shall be determined by the U.S. Food & Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee. Other specification data is included in the solicitation. Successful contractor must have FDA Approval, and the vaccine must be U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immu

Why This Opportunity Matters

The Department of DEFENSE is actively seeking qualified contractors for biological product (except diagnostic) manufacturing in PHILADELPHIA, PA.